A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in Psoriasis
Clinical trial NCT03445013 · COMPLETED
Trial details
- NCT number
- NCT03445013
- Sponsor
- Novan, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-13
- Primary completion
- 2018-01-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.